Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO-Centre for Genomics andOncological Research–Pfizer/University of Granada, Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO-Centre for Genomics andOncological Research–Pfizer/University of Granada, Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO-Centre for Genomics andOncological Research–Pfizer/University of Granada, Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO-Centre for Genomics andOncological Research–Pfizer/University of Granada, Department of Otolaryngology, Complexo Hospitalario de Pontevedra, Division of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Department of Otolaryngology, Hospital Universitario de Salamanca, Karolinska Institutet, Universite du Luxembourg, Karolinska Institutet and Instituto de Investigación Biosanitaria ibs. GRANADA